Search research articles
Contact Us
Filters
Showing results (51-60 of 297) with videos related to
Page
of 30
Sort By:
Haematology and Blood Transfusion
|
January 1, 1987
Activation of natural killer function through the T11/E rosette receptor
R E Schmidt, S F Schlossman, E L Reinherz, et al.
Chemotherapy
|
January 1, 1991
In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria
A Louie, A L Baltch, W J Ritz, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1991
Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents
A Louie, A L Baltch, W J Ritz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1988
Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses
D A Hafler, J Ritz, S F Schlossman, et al.
The American Journal of Pathology
|
March 1, 1996
Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease
P L Nguyen, N L Harris, J Ritz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1997
CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells
H Ida, M J Robertson, S Voss, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1980
Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro
J Ritz, J M Pesando, J Notis-McConarty, et al.
The Journal of Clinical Investigation
|
October 1, 1981
Expression of myeloid differentiation antigens on normal and malignant myeloid cells
J D Griffin, J Ritz, L M Nadler, et al.
Immunology
|
August 14, 1999
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor
F Borrego, M J Robertson, J Ritz, et al.
Progress in Clinical and Biological Research
|
January 1, 1994
Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia
M J Robertson, D C Roy, R M Stone, et al.
Page
of 30
Search research articles
Search
Showing results (51-60 of 297) with videos related to
Sort By:
Page
of 30
Haematology and Blood Transfusion
|
January 1, 1987
Activation of natural killer function through the T11/E rosette receptor
R E Schmidt, S F Schlossman, E L Reinherz, et al.
Chemotherapy
|
January 1, 1991
In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria
A Louie, A L Baltch, W J Ritz, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1991
Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents
A Louie, A L Baltch, W J Ritz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1988
Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses
D A Hafler, J Ritz, S F Schlossman, et al.
The American Journal of Pathology
|
March 1, 1996
Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease
P L Nguyen, N L Harris, J Ritz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1997
CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells
H Ida, M J Robertson, S Voss, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1980
Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro
J Ritz, J M Pesando, J Notis-McConarty, et al.
The Journal of Clinical Investigation
|
October 1, 1981
Expression of myeloid differentiation antigens on normal and malignant myeloid cells
J D Griffin, J Ritz, L M Nadler, et al.
Immunology
|
August 14, 1999
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor
F Borrego, M J Robertson, J Ritz, et al.
Progress in Clinical and Biological Research
|
January 1, 1994
Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia
M J Robertson, D C Roy, R M Stone, et al.
Page
of 30